Marsico Capital Management LLC Amgen Inc Transaction History

Marsico Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $8.24 Million - $9.26 Million	-49,623 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $7.24 Million - $8.46 Million	-42,723 Reduced 46.26%	49,623 $8.46 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $4.95 Million - $5.54 Million	-29,350 Reduced 24.12%	92,346 $16.1 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $1.99 Million - $2.27 Million	-11,899 Reduced 8.91%	121,696 $22.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	133,595	133,595 $23 Million

3,082

417M

7.24M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Marsico Capital Management LLC with notifications on news.